8:00 am Check-In & Coffee
9:00am – 12:00pm | Workshop A
Balancing Quality, Consistency & Scalability of Starting Cell Lines through Strategic Selection
Synopsis
Choosing the right iPSC starting line is fundamental to influencing safety, efficacy, and manufacturability. Key factors such as donor selection, genomic stability, and differentiation potential must be carefully evaluated alongside evolving regulatory expectations. This session will explore best practices for optimizing cell line selection, balancing standardization with therapy-specific requirements.
Join this workshop to:
- Analyze the impact of donor variability on iPSC line performance, including how genetic differences can influence differentiation capacity and final therapeutic outcomes
- Address challenges in acquiring GMP-grade iPSC lines, focusing on overcoming cost and regulatory barriers
- Discuss strategies for optimizing starting iPSC lines, including isogenic lines or barcoded ‘villages’ to reduce variability
- Assess predictive assays for iPSC differentiation in various contexts, ensuring selected lines are suitable for specific therapeutic applications
12:00 pm Lunch Break & Networking
1:00pm – 4:00pm | Workshop B
Uniting the iPSC Community to Identify Opportunities for Harmonization in QC Testing & iPSC Differentiation
Synopsis
As the iPSC field evolves, standardization of QC testing and differentiation processes remains a critical challenge. This workshop will bring together key stakeholders to identify opportunities for harmonizing quality control measures and differentiation protocols across the iPSC industry.
Join this workshop to:
- Highlight how collaboration and industry-driven standardization can reduce inefficiencies and accelerate the development of iPSC-based products across clinical stages
- Identify commonalities between different iPSC platforms to enhance crossfunctional learning and work towards standardizing procedures
- Discuss best practices to define critical quality attributes for iPSCs that can be agreed upon across multiple processes
- Explore different approaches to QC testing such as residual IPS, potency, and toxicology assays that can be harmonized